Chitti, S.V.; Marzan, A.L.; Shahi, S.; Kang, T.; Fonseka, P.; Mathivanan, S.
Repurposing of Antibiotic Sulfisoxazole Inhibits Lipolysis in Pre-Clinical Model of Cancer-Associated Cachexia. Biology 2021, 10, 700.
https://doi.org/10.3390/biology10080700
AMA Style
Chitti SV, Marzan AL, Shahi S, Kang T, Fonseka P, Mathivanan S.
Repurposing of Antibiotic Sulfisoxazole Inhibits Lipolysis in Pre-Clinical Model of Cancer-Associated Cachexia. Biology. 2021; 10(8):700.
https://doi.org/10.3390/biology10080700
Chicago/Turabian Style
Chitti, Sai V., Akbar L. Marzan, Sanjay Shahi, Taeyoung Kang, Pamali Fonseka, and Suresh Mathivanan.
2021. "Repurposing of Antibiotic Sulfisoxazole Inhibits Lipolysis in Pre-Clinical Model of Cancer-Associated Cachexia" Biology 10, no. 8: 700.
https://doi.org/10.3390/biology10080700
APA Style
Chitti, S. V., Marzan, A. L., Shahi, S., Kang, T., Fonseka, P., & Mathivanan, S.
(2021). Repurposing of Antibiotic Sulfisoxazole Inhibits Lipolysis in Pre-Clinical Model of Cancer-Associated Cachexia. Biology, 10(8), 700.
https://doi.org/10.3390/biology10080700